Le Lézard
Classified in: Health, Science and technology
Subjects: CCA, TDS, FVT

REGENXBIO to Participate in Upcoming Investor Conferences


ROCKVILLE, Md., May 10, 2024 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced it will participate in the following upcoming investor conferences:

BofA Securities Health Care Conference 2024
Fireside Chat: Wednesday, May 15, 2024 at 2:20 p.m. ET
Location: Las Vegas, NV

Stifel 2024 Tailoring Genes Genetic Medicines Forum
Fireside Chat: Tuesday, May 28, 2024 at 4:10 p.m. ET
Location: Virtual

A live webcast of the presentation at the BofA conference and fireside chat at the Stifel forum can be accessed in the Investors section of REGENXBIO's website at www.regenxbio.com. An archived replay of the webcast will be available for approximately 30 days following the presentation.

ABOUT REGENXBIO Inc.

REGENXBIO is a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy. Since its founding in 2009, REGENXBIO has pioneered the development of AAV Therapeutics, an innovative class of gene therapy medicines. REGENXBIO is advancing a pipeline of AAV Therapeutics for retinal and rare diseases, including ABBV-RGX-314 for the treatment of wet AMD and diabetic retinopathy, being developed in collaboration with AbbVie, RGX-202 for the treatment of Duchenne and RGX-121 for the treatment of MPS II. Thousands of patients have been treated with REGENXBIO's AAV Therapeutic platform, including Novartis' ZOLGENSMA for children with spinal muscular atrophy. Designed to be one-time treatments, AAV Therapeutics have the potential to change the way healthcare is delivered for millions of people. For more information, please visit www.regenxbio.com.

Contacts:

Dana Cormack
Corporate Communications
[email protected] 

Investors:
Chris Brinzey, ICR Westwicke
339-970-2843
[email protected]

(PRNewsfoto/REGENXBIO Inc.)

 

SOURCE REGENXBIO Inc.


These press releases may also interest you

at 15:07
Studies Show Linked Biological Pathways Driving Skin Inflammation
A certain biological pathway, a set of linked reactions in the body, drives the inflammation seen in the skin disease psoriasis, a new study finds. The work could lead to improved therapies for all inflammatory skin diseases, including atopic and...

at 14:48
New Tool Flags Hidden Sexual Struggles in Female Partners of Patients With Prostate Cancer
The partners of patients with prostate cancer grapple with their own quality-of-life issues that impact their sexual well-being, a new study shows. Using the first questionnaire of its kind, the authors uncovered key challenges faced by patients'...

at 14:15
InventHelp Inventor Develops Tracheal Bibb for Patients with Tracheostomy Tubes (BRK-4289)
"I'm a nurse and I thought there should be a way to combine a tracheal tie together with a tracheal sponge or bib," said an inventor, from Tuscaloosa, Ala., "so I invented the TRACHEAL BIBB. My design would secure and protect the tracheal stoma, and...

at 14:15
The Inner Circle Acknowledges, Brian J. Hudec, DMD as a Pinnacle Lifetime Member
Prominently featured in The Inner Circle, Brian J. Hudec, DMD is acknowledged as a Pinnacle Lifetime Member for his contributions to the Dentistry field. Dr. Hudec, a compassionate and dedicated dentist, is making a difference in the field of...

at 14:05
Progentos Therapeutics Closes $65 Million Series A Financing to Advance Treatments for Multiple Sclerosis and Other Degenerative Diseases
Progentos Therapeutics, a biotech company addressing the critical unmet need to regenerate myelin and restore function for patients with Multiple Sclerosis (MS) and other demyelinating diseases, today announced its launch and the closing of a $65...

at 14:01
University of Chicago Invites the Public "Inside the Lab"
University labs around the world are catalysts for breakthrough discoveries that improve humanity, but their work can be shrouded in mystery. Inside the Lab, a new video and Q&A series from the University of Chicago, pulls back the curtain for a...

More news about Health...


News published on and distributed by: